Vertex Pharmaceuticals Inc operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Vertex Pharmaceuticals Inc with three other
companies in this sector in UNITED STATES :
sales of $3.16 billion
of which 77%
was Specialty Brands),
Perrigo Company PLC
of which 51%
was CSCA), and
Alexion Pharmaceuticals, Inc.
of which 80%
During the year ended December of 2019, sales at
Vertex Pharmaceuticals Inc were $4.16 billion.
increase of 36.6%
versus 2018, when the company's sales were $3.05 billion.
This was the fifth consecutive year of sales increases at Vertex Pharmaceuticals Inc
(and since 2014, sales have increased a total of 617%).